您的当前位置:首页正文

ANTI-CANCER EFFECTS OF PROTEASOME INHIBITORS IN CO

2022-07-15 来源:尚佳旅游分享网
专利内容由知识产权出版社提供

专利名称:ANTI-CANCER EFFECTS OF PROTEASOME

INHIBITORS IN COMBINATION WITHGLUCOCORTICOIDS, ARSENIC CONTAININGCOMPOUNDS, AND ASCORBIC ACID

发明人:BERENSON, James R.申请号:EP15807258.7申请日:20150610公开号:EP3154596A1公开日:20170419

摘要:The present invention provides methods of treatment for hematologicalmalignancies involving synergistic combination of a proteasome inhibitor, a

glucocorticoid, an arsenic-containing compound, and ascorbic acid or a derivative thereofprovide an unexpected efficacy in the treatment for hematological disorders. Thehematological disorders treated by the current invention include multiple myeloma, andmay also include hematological disorders that are refractory to prior cancer treatments,or relapsed hematologic disorders.

申请人:Institute for Myeloma & Bone Cancer Research

地址:9201 Sunset Boulevard, Suite 300 West Hollywood, CA 90069 US

国籍:US

代理机构:Cooley (UK) LLP

更多信息请下载全文后查看

因篇幅问题不能全部显示,请点此查看更多更全内容